Influence of Aripiprazole on Life Quality of the Patients with Schizophrenia
HU Zheng-da
Abstract
HU Zheng-da
Abstract
Objective: To compare the efficacy and safety of aripiprazole and clozapine in the treatment of schizophrenia and their influence on the patients' life quality.Methods: All 60 patients with schizophrenia diagnosed according to CCMD-3 criteria were randomly assigned to two groups treated with aripiprazole or clozapine respectively for 8 weeks.The Positive and Negative Syndrome Scale(PANSS),Treatment Emergent Side effect Scale(TESS) and WHO Quality of Life-100(QOL-100) were used to evaluate the efficacy and adverse effect and influence on the patients' life quality respectively.Results: After 8 weeks,the score of PANSS had no significant difference between the two groups,but the incidence of adverse effects was lower and the score of QOL-100 was higher significantly in the aripiprazole group than in the clozapine group.Conclusion: Aripiprazole is as effective as clozapine in treatment of schizophrenia.But it is much safer than and its influence on the patients' life quality is superior to clozapine.
OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To compare the efficacy and safety of aripiprazole and clozapine in the treatment of schizophrenia and their influence on the patients' life quality.Methods: All 60 patients with schizophrenia diagnosed according to CCMD-3 criteria were randomly assigned to two groups treated with aripiprazole or clozapine respectively for 8 weeks.The Positive and Negative Syndrome Scale(PANSS),Treatment Emergent Side effect Scale(TESS) and WHO Quality of Life-100(QOL-100) were used to evaluate the efficacy and adverse effect and influence on the patients' life quality respectively.Results: After 8 weeks,the score of PANSS had no significant difference between the two groups,but the incidence of adverse effects was lower and the score of QOL-100 was higher significantly in the aripiprazole group than in the clozapine group.Conclusion: Aripiprazole is as effective as clozapine in treatment of schizophrenia.But it is much safer than and its influence on the patients' life quality is superior to clozapine.
Key concepts: Aripiprazole, Clozapine, Schizophrenia (object-oriented programming), Quality of life (healthcare), Adverse effect, Positive and Negative Syndrome Scale, Medicine, Internal medicine